中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2008, 20(5): 800-
糖皮质激素受体及其选择性调节剂研究进展
李群益, 颜建华, 王明伟*
(中国科学院上海药物研究所,国家新药筛选中心,上海 201203)
摘 要:糖皮质激素(glucocorticoids, GCs)是临床上广泛使用的一类抗炎药物,在体内主要通过糖皮质激素受体(glucocorticoid receptor, GR)发挥生理和药理作用。GR是核受体超家族的成员之一,为配体激活的转录因子,在机体的多种生理和病理活动中扮演重要的角色。随着对GR信号通路的深入研究,寻找针对糖皮质激素受体的新型调节剂,以期将抗炎作用和现有糖皮质激素的副作用相分离,已经成为新药发现的研究热点。本文对近年来GR的分子结构、生物学作用及其选择性调节剂的研究进展作一简要的介绍。
关键词:糖皮质激素;受体;调节剂
中图分类号:Q571; R979.1  文献标识码:A
 
Research progresses in glucocorticoid receptor and selective glucocorticoid receptor modulators
LI Qun-yi, YAN Jian-hua, WANG Ming-wei*
(The National Center for Drug Screening, Shanghai Institute of Materia Medica,Chinese Academy of Sciences, Shanghai 201203, China)
Abstract: Glucocorticoids (GCs) are widely used as anti-inflammatory therapeutics. Their physiological and pharmacological actions are mainly mediated by glucocorticoid receptor (GR). As a member of the nuclear receptor superfamily, GR is a ligand-activated transcriptional factor and plays important roles in many physiological and pathological processes. With in-depth knowledge on the molecular mechanisms involved in GR-related signal transduction pathways, discovery of novel GR modulators has become one of the focal points in drug development, aiming at increasing efficacies and reducing side effects. In this review, we briefly describe the current understanding of molecular structure, biological functions and selective modulators of GR.
Key words: glucocorticoids; receptor; modulators
 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第2954868 位访问者,欢迎!